TCM combination therapy may increase therapeutic effects and reduce toxicity when combined with EGFR-TKIs for advanced NSCLC as well, indicating that this combination maximizes the duration of the EGFR- TKI treatment for NSCLC patients. This evidence concerns the gene EGFR and non-small cell lung carcinoma.